US 11083753
Targeted replacement of endogenous T cell receptors
granted A61KA61K40/11A61K40/32
Quick answer
US patent 11083753 (Targeted replacement of endogenous T cell receptors) held by The Regents of the University of California expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K40/11, A61K40/32, A61K40/4269